secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quanterix Corp (QTRX)
CIK:        0001503274
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001503274-25-000002
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quanterix to acquire Akoya Biosciences in stock deal; exchange ratio 0.318
--------------------------------------------------------------------------

- Akoya shareholders to receive 0.318 Quanterix shares per share; no cash consideration except for fractional shares.
- Voting agreements from ~55.9% of Akoya stock and ~6.2% of Quanterix stock; lock-up agreements cover ~35.7% of QTRX shares for 90 days.
- Termination fees: $7M from Akoya, $9M from Quanterix; Quanterix may provide $30M bridge convertible notes after March 15, 2025.
- Expected close by July 9, 2025 (extendable to Jan 9, 2026); Akoya to nominate two directors to Quanterix board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503274/000150327425000002/0001503274-25-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503274/000150327425000002/qtrx-20250109.htm
  HTML page:      https://secwatch.observer/filing/0001503274-25-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer